2224P Identifying prognostic factors in patients with radioiodine-refractory differentiated thyroid carcinoma (RR-DTC) treated with tyrosine kinase inhibitors (TKI): Data from REGETNE registry

Autor: San Roman Gil, M.V., Hernando, J., Granados, A.R., Carmona, A., Marquina Ospina, G., Bella, M.R., Castelo, B., Campos Ramirez, S.E., Molina Cerrillo, J., Ruz-Caracuel, I., Valderrabano, P., Luengo Pierrard, P., Roca Herrera, M., Garcia Alvarez, A., Pozas Perez, J., Gonzalez Merino, C., Alonso Gordoa, T., Capdevila Castillon, J.
Zdroj: In Annals of Oncology October 2023 34 Supplement 2:S1146-S1146
Databáze: ScienceDirect